Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12). [electronic resource]
Producer: 20000816Description: 369-78 p. digitalISSN:- 1524-9557
- Antibodies, Monoclonal -- immunology
- Carcinoma, Renal Cell -- immunology
- Cytokines -- immunology
- Dendritic Cells -- drug effects
- Drug Therapy, Combination
- Granulocyte-Macrophage Colony-Stimulating Factor -- immunology
- Histocompatibility Antigens Class II -- immunology
- Humans
- Immunologic Factors -- administration & dosage
- Interferon-alpha -- administration & dosage
- Interleukin-12 -- administration & dosage
- Interleukin-2 -- administration & dosage
- Interleukin-4 -- immunology
- Kidney Neoplasms -- immunology
- Lymphocyte Culture Test, Mixed
- Melanoma -- immunology
- Monocytes -- immunology
- Neoplasm Metastasis
- Peptides -- immunology
- Recombinant Proteins -- therapeutic use
- T-Lymphocytes -- immunology
- Tetanus Toxoid
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.